Economic evaluations (summary)
Study reference Study characteristics Patient characteristics Is the new intervention cost-effective? Are the outcomes of the economic evaluation uncertain and/or variable? Balance between health benefits, side effects, and risk Overall conclusion Transferability (see table transferability) Generalizability of the study results Implementation problems

de Kinderen et al., 2016

Type of study

trial based

 

Country

The Netherlands

 

Perspective

health care

 

Refractory epilepsy


no

QALY gain

No (no adverse events of ADR taken into account

 

Transferable

Generalizable

de Kinderen et al., 2015

Type of study

Model based

Country

The Netherlands

Perspective

health care

 

Refractory epilepsy


no

yes

QALY gain

No (side effects not taken into account, page 121)

 

Transferable

Generalizable

Wijnen et al., 2017

Type of study

trial based

Country

The Netherlands

Perspective

Societal perspective

 

Refractory epilepsy


No


Yes

QALY gain

Yes (side-effects were taken into account (SIDEAD)

Transferable

Generalizable